03
Sep

Third Rock Ventures’ Voyager Therapeutics has named Steven Paul as its full-time CEO, tasking the longtime Eli Lilly R&D exec with shepherding its gene therapy candidates into clinical trials.

…read more

Source: Gene therapy biotech Voyager snags a former Lilly exec to take the reins

    

0 No comments